[Thrombotic Thrombocytopenic Purpura. Reduced Activity of Von Willebrand Factor Cleaving Protease]

Overview

Journal Nervenarzt

Specialty Neurology

Date 2004 Mar 23

PMID 15034657

Authors

A Kunze

C Terborg

J Gerth

G Heide

O W Witte

Affiliations

Soon will be listed here.

Abstract

Thrombotic thrombocytopenic purpura (TTP) is a rare thrombotic microangiopathy. Besides anemia and thrombocytopenia, neurological impairment is common in TTP. A 42-year-old woman was admitted to a department of obstetrics/gynecology because of severe vaginal bleeding due to thrombocytopenia. After platelet transfusion, the patient developed a reduced level of consciousness, confusion, headache, and fever. CT scan did not show pathological changes. Transcranial Doppler sonography revealed increased blood flow velocities of all basal cerebral arteries. Because encephalitis was suspected the patient was transferred to the neurological department. CSF and cerebral magnetic resonance imaging studies were normal. Finally, the detection of schistocytes in the peripheral blood smear and the strong elevation of LDH led to the diagnosis of TTP. After plasma exchange over 3 consecutive days the patient achieved complete remission. The diagnosis was confirmed by laboratory tests (activity of ADAMTS13 <5%, IgG antibodies against ADAMTS13). Platelet transfusion may adversely affect the outcome of patients with suspected TTP. Severely deficient activity of the von Willebrand factor cleaving protease (ADAMTS13) is specific for thrombotic thrombocytopenic purpura.

References

Bianchi V, Robles R, Alberio L, Furlan M, Lammle B . Von Willebrand factor-cleaving protease (ADAMTS13) in thrombocytopenic disorders: a severely deficient activity is specific for thrombotic thrombocytopenic purpura. Blood. 2002; 100(2):710-3. DOI: 10.1182/blood-2002-02-0344. View

Levy G, Nichols W, Lian E, Foroud T, McClintick J, McGee B . Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura. Nature. 2001; 413(6855):488-94. DOI: 10.1038/35097008. View

George J, Vesely S . Thrombotic thrombocytopenic purpura: from the bench to the bedside, but not yet to the community. Ann Intern Med. 2003; 138(2):152-3. DOI: 10.7326/0003-4819-138-2-200301210-00018. View

Allford S, Hunt B, Rose P, Machin S . Guidelines on the diagnosis and management of the thrombotic microangiopathic haemolytic anaemias. Br J Haematol. 2003; 120(4):556-73. DOI: 10.1046/j.1365-2141.2003.04049.x. View

Bennett C, Connors J, Carwile J, Moake J, Bell W, Tarantolo S . Thrombotic thrombocytopenic purpura associated with clopidogrel. N Engl J Med. 2000; 342(24):1773-7. DOI: 10.1056/NEJM200006153422402. View

Veyradier A, Obert B, Houllier A, Meyer D, Girma J . Specific von Willebrand factor-cleaving protease in thrombotic microangiopathies: a study of 111 cases. Blood. 2001; 98(6):1765-72. DOI: 10.1182/blood.v98.6.1765. View

Dong J, Moake J, Bernardo A, Fujikawa K, Ball C, Nolasco L . ADAMTS-13 metalloprotease interacts with the endothelial cell-derived ultra-large von Willebrand factor. J Biol Chem. 2003; 278(32):29633-9. DOI: 10.1074/jbc.M301385200. View

Moake J . Thrombotic microangiopathies. N Engl J Med. 2002; 347(8):589-600. DOI: 10.1056/NEJMra020528. View

Tsai H, Lian E . Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura. N Engl J Med. 1998; 339(22):1585-94. PMC: 3159001. DOI: 10.1056/NEJM199811263392203. View

10.

Chemnitz J, Schulz A, Diehl V, Sohngen D . [Thrombotic-thrombocytopenic purpura (Moschcowitz syndrome)]. Med Klin (Munich). 2001; 96(6):343-50. DOI: 10.1007/pl00002214. View

11.

Assink K, Schiphorst R, Allford S, Karpman D, Etzioni A, Brichard B . Mutation analysis and clinical implications of von Willebrand factor-cleaving protease deficiency. Kidney Int. 2003; 63(6):1995-9. DOI: 10.1046/j.1523-1755.63.6s.1.x. View

12.

George J, Sadler J, Lammle B . Platelets: thrombotic thrombocytopenic purpura. Hematology Am Soc Hematol Educ Program. 2002; :315-34. DOI: 10.1182/asheducation-2002.1.315. View

13.

Tsai H . Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura. J Mol Med (Berl). 2002; 80(10):639-47. DOI: 10.1007/s00109-002-0369-8. View

14.

Ohlmann D, Hamann G, Hassler M, Schimrigk K . [Involvement of the central nervous system in hemolytic uremic syndrome/thrombotic thrombocytopenic purpura]. Nervenarzt. 1996; 67(10):880-2. DOI: 10.1007/s001150050066. View

15.

Chung D, Fujikawa K . Processing of von Willebrand factor by ADAMTS-13. Biochemistry. 2002; 41(37):11065-70. DOI: 10.1021/bi0204692. View

16.

Crowther M, Heddle N, Hayward C, Warkentin T, Kelton J . Splenectomy done during hematologic remission to prevent relapse in patients with thrombotic thrombocytopenic purpura. Ann Intern Med. 1996; 125(4):294-6. DOI: 10.7326/0003-4819-125-4-199608150-00006. View

17.

Chemnitz J, Draube A, Scheid C, Staib P, Schulz A, Diehl V . Successful treatment of severe thrombotic thrombocytopenic purpura with the monoclonal antibody rituximab. Am J Hematol. 2002; 71(2):105-8. DOI: 10.1002/ajh.10204. View

18.

Tsai H, Shulman K . Rituximab induces remission of cerebral ischemia caused by thrombotic thrombocytopenic purpura. Eur J Haematol. 2003; 70(3):183-5. DOI: 10.1034/j.1600-0609.2003.00026.x. View

19.

Shumak K, Rock G, Nair R . Late relapses in patients successfully treated for thrombotic thrombocytopenic purpura. Canadian Apheresis Group. Ann Intern Med. 1995; 122(8):569-72. DOI: 10.7326/0003-4819-122-8-199504150-00002. View

20.

Bennett C, Kiss J, Weinberg P, Pinevich A, Green D, Kwaan H . Thrombotic thrombocytopenic purpura after stenting and ticlopidine. Lancet. 1998; 352(9133):1036-7. DOI: 10.1016/s0140-6736(05)60079-7. View